XBiotech Inc. (XBIT) DCF Valuation

XBiotech Inc. (XBIT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

XBiotech Inc. (XBIT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and boost precision with our (XBIT) DCF Calculator! Utilizing real data from XBiotech Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and value XBiotech like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 44.0 18.4 4.0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 -58.19 -78.2 -100 -59.1 -59.1 -59.1 -59.1 -59.1
EBITDA -28.9 -16.0 -22.4 -31.9 -35.8 .0 .0 .0 .0 .0
EBITDA, % 100 -36.45 -121.96 -794.91 100 -7.29 -7.29 -7.29 -7.29 -7.29
Depreciation 2.4 2.2 2.6 2.6 1.7 .0 .0 .0 .0 .0
Depreciation, % 100 5.09 14.4 65.19 100 56.93 56.93 56.93 56.93 56.93
EBIT -31.2 -18.3 -25.1 -34.5 -37.5 .0 .0 .0 .0 .0
EBIT, % 100 -41.54 -136.36 -860.1 100 -8.31 -8.31 -8.31 -8.31 -8.31
Total Cash 714.6 237.4 237.0 217.5 200.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 4.1 9.0 1.8 .9
Account Receivables, % 100 9.35 48.67 43.99 100
Inventories .0 -6.6 -9.0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 -14.94 -48.67 0 100 27.28 27.28 27.28 27.28 27.28
Accounts Payable 2.1 2.5 2.1 2.4 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 5.66 11.25 60.05 100 55.39 55.39 55.39 55.39 55.39
Capital Expenditure -.2 -3.7 -3.5 -.6 -.4 .0 .0 .0 .0 .0
Capital Expenditure, % 100 -8.47 -19.16 -14.59 100 -8.44 -8.44 -8.44 -8.44 -8.44
Tax Rate, % -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
EBITAT -29.1 -16.0 -17.2 -33.8 -37.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -24.8 -14.7 -20.9 -33.2 -35.6 -1.6 .0 .0 .0 .0
WACC, % 11.12 11.12 11.12 11.12 11.12 11.12 11.12 11.12 11.12 11.12
PV UFCF
SUM PV UFCF -1.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -200
Equity Value 199
Diluted Shares Outstanding, MM 30
Equity Value Per Share 6.52

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios.
  • Real-World Data: XBiotech Inc.’s (XBIT) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive XBiotech Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify yellow-highlighted cells for metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
  • Designed for All Skill Levels: A straightforward, user-friendly layout tailored for investors, CFOs, and consultants.

How It Works

  • Step 1: Download the prebuilt Excel template featuring XBiotech Inc. (XBIT) data.
  • Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including the intrinsic value of XBiotech Inc. (XBIT).
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose XBiotech Inc. (XBIT)?

  • Streamlined Process: Quickly access vital data without the hassle of building models from the ground up.
  • Enhanced Precision: Utilize dependable financial metrics and calculations to minimize valuation errors.
  • Completely Adaptable: Modify the framework to align with your specific forecasts and assumptions.
  • User-Friendly Design: Intuitive visuals and outputs facilitate straightforward analysis of results.
  • Endorsed by Professionals: Crafted for industry experts who prioritize both accuracy and functionality.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling XBiotech Inc. (XBIT) stock.
  • Financial Analysts: Enhance valuation processes with ready-to-use financial models specific to XBiotech Inc. (XBIT).
  • Consultants: Provide professional valuation insights on XBiotech Inc. (XBIT) to clients efficiently and accurately.
  • Business Owners: Gain insights into how biotech companies like XBiotech Inc. (XBIT) are valued to inform your own business strategy.
  • Finance Students: Explore valuation techniques using real-world data and scenarios related to XBiotech Inc. (XBIT).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled XBiotech Inc. (XBIT) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for XBiotech Inc. (XBIT).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.